(CNN) — Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will Read More Skip to content ...

Novo Nordisk today presented results from the phase 3b FRONTIER5 trial showing that a direct switch to investigational Mim8 (denecimig) prophylaxis from emicizumab treatment, without a washout ...

Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply ...

Instead of a preloaded injector pen, patients will use a syringe to draw out the medicine. Tirzepatide, the active ingredient in Zepbound and Mounjaro, ...

Lilly launches lower-price weight-loss drug without injector pen. Share Copy Link. Copy {copyShortcut} to copy Updated: 12:57 PM EDT Aug 27, 2024 NOW ANOTHER COMPANY IS SOUNDING THE ALARM.

Instead of a preloaded injector pen, patients will use a syringe to draw out the medicine. Tirzepatide, the active ingredient in Zepbound and Mounjaro, is part of new class of medications used to ...